Cargando…
Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
Autores principales: | Preti, Paola S., Russo, Mariaconcetta, Caneva, Luca, Reduzzi, Margherita, Calabretta, Francesca, Spataro, Carmine, Grimaldi, Paolo, De Amici, Mara, Testa, Giorgia, Iotti, Giorgio A., Mojoli, Francesco, Di Sabatino, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054612/ https://www.ncbi.nlm.nih.gov/pubmed/33915353 http://dx.doi.org/10.1016/j.thromres.2021.04.016 |
Ejemplares similares
-
Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020) -
Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group
por: Ray, Joel G., et al.
Publicado: (2021) -
The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients
por: Calabretta, F., et al.
Publicado: (2022) -
Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021) -
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)